plx-8394
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2014 (NCT02012231)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
BRAF inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3545005 ↗
Also known as
- plx8394
- plx8394
- plx-8394
- plx-8394
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02428712 | Phase 1/Phase 2 (Phase 2) | Apr 1, 2015 | Plexxikon |
| NCT02012231 | Phase 1/Phase 2 (Phase 2) | Feb 1, 2014 | Plexxikon, University of Utah |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Plexxikon | For profit | 2 | 2 | 1 | 2014 |
| University of Utah | Academic/Hospital | 1 | 0 | 1 | 2014 |
2 organizations
Page 1 / 1